Clinical trial
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis…
NCT00215865 · Hepatitis Resource Network, Other · Completed
Key facts
| NCT number | NCT00215865 |
|---|---|
| Title | PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy |
| Official title | HRN 003PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy |
| Lead sponsor | Hepatitis Resource Network, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C Virus Infection |
| Intervention type | Drug |
| Interventions | PEGIntron plus ribavirin |
| Enrollment | 600 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: